Zenoaq

Q: What is Zenoaq's official website?

Zenoaq's official website is www.zenoaq.jp

Q: What is Zenoaq's Revenue?

Zenoaq's revenue is <$5 Million

Q: What industry does Zenoaq belong to?

Zenoaq is in the industry of: Manufacturing , Pharmaceuticals , Business Services

Q: What technology does Zenoaq use?

Some of the popular technologies that Zenoaq uses are: Microsoft 365, Piped Bits SPIRAL, Symantec Email Security, Microsoft Exchange Online

Q: What does Zenoaq do?

Established in 1946, Zenoaq is a leading animal health company in Japan. With a workforce of nearly 700 employees and the generation of 24.2 billion in sales (approximately US$195 million) in the 2014 fiscal year, Zenoaq has a solid business model focused on R&D, manufacturing and importation of animal health products, contributing to a broad produ... ct portfolio for production and companion animals. In addition, Zenoaq, headquartered in Fukushima, has the widest distribution network for veterinary products in Japan, supported by a strong direct sales force. In June 2014, Zenoaq launched Allermmune HDM, a first-of-its-kind desensitization therapy for house dust mite-induced canine atopic dermatitis, reflecting the company's increased focus on an innovative pipeline for the companion animal market. Zenoaq's partners include Merial, Mars, Intervet, DSM Nutrition as well as IDEXX Laboratories. Read More

Q: Is Zenoaq a public company?

Zenoaq is private company therefore does not currently have an official ticker symbol

Manufacturing · California, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

23591 El Toro Rd Ste 180, Lake Forest, C...

Website

www.zenoaq.jp

Revenue

<$5 Million

Industry

Manufacturing

Pharmaceuticals

Business Services

Research & Development

About Zenoaq

Established in 1946, Zenoaq is a leading animal health company in Japan. With a workforce of nearly 700 employees and the generation of 24.2 billion in sales (approximately US$195 million) in the 2014 fiscal year, Zenoaq has a solid business model focused on R&D, manufacturing and importation of animal health products, contributing to a broad product portfolio for production and companion animals. In addition, Zenoaq, headquartered in Fukushima, has the widest distribution network for veterinary products in Japan, supported by a strong direct sales force. In June 2014, Zenoaq launched Allermmune HDM, a first-of-its-kind desensitization therapy for house dust mite-induced canine atopic dermatitis, reflecting the company's increased focus on an innovative pipeline for the companion animal market. Zenoaq's partners include Merial, Mars, Intervet, DSM Nutrition as well as IDEXX Laboratories.Explore more